Breast Imaging Market Size by Technology, End User and Region - Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2034
Overview
The Breast Imaging Market size was valued at USD 5.07 Billion in 2025 and the total Breast Imaging revenue is expected to grow at a CAGR of 6.79% from 2026 to 2034, reaching nearly USD 9.16 Billion.
Breast Imaging Market Overview:
Breast imaging, a specialized field within diagnostic radiology, encompasses various imaging procedures such as screening mammography, diagnostic mammography, breast tomosynthesis, MRI, and breast ultrasound. The primary objective of these screenings and imaging techniques is the early detection of breast cancers. Regular mammograms play a crucial role in reducing the risk of breast cancer, showing a 14% reduction in ages 50-59 and a 33% reduction in ages 60-69. Given the escalating incidences and high prevalence of breast cancer among women worldwide, there is a growing demand for advanced breast imaging technologies. The scope of the breast imaging market includes applications related to breast cancer, breast diseases, and other conditions, contributing to an increased market share.
Breast Imaging Market Size, Growth & Share Analysis
To know about the Research Methodology:-Request Free Sample Report
The global breast imaging market is witnessing growth, driven by factors such as ongoing research and development initiatives. Additionally, the approval of novel products in various countries is fostering a positive outlook for the growth of the breast imaging market on a global scale.
Breast Imaging Market Dynamics:
The research report presents a complete overview by providing detailed information about the current breast imaging market is witnessing growth, driven by factors such as ongoing research and development initiatives. trends, existing drivers, growth opportunities and potentials, and emerging challenges. The breast imaging market is witnessing growth, driven by factors such as ongoing research and development initiatives. report has up-to-date insights about market dynamics and breast imaging market scenarios that can shape the overall market performance and output during the forecast period, 2026 to 2034.
Breast Imaging Market Drivers:
Growth in the international breast imaging technology sector in breast imaging market is driven primarily by the increased prevalence of breast cancer, increased demand for early detection, increased funding from private and government agencies for the development of medical infrastructure, and an increase in the female population. It has been. approximately 281,550 new cases of invasive breast cancer were diagnosed in women in the United States. In addition, one in eight women in the United States will develop invasive breast cancer in their lifetime. In addition, increasing approval of breast imaging technology is driving the growth of the breast imaging technology market. For example, in April , the US Food and Drug Administration (FDA) approved Seno Medical's Imagio P200003 breast imaging system for use in breast tissue imaging.
The presence of leading manufacturers of advanced breast imaging technology devices is contributing to the growth of the breast imaging market. For example, in October , medical imaging company Delphinus Medical Technologies announced pre-approval by the US FDA for the SoftVue 3D whole-breast ultrasound imaging system. It is used to prevent breast cancer. Moreover, the increasing prevalence of women over the age of 45, who are prone to breast cancer, is driving the breast imaging market growth. According to the American Cancer Society, it has been observed that about half of women population over the age of 62 are diagnosed with breast cancer.
In addition, technological developments in the medical equipment sector to manufacture advanced breast imaging technology are expected to provide an opportunity for the breast imaging market to expand during the forecast period. In addition, the increasing number of screening techniques and the increasing demand for early detection are driving the breast imaging market growth.
Government and private organization initiatives to develop the medical device market are driving the growth of the breast imaging market. However, the high cost of breast cancer detection and the rigorous regulatory approval process limits market growth during the forecast period of the breast imaging market.
Breast Imaging Market Restraints:
Breast imaging is essential for the early detection of breast cancer. However, some breast imaging methods use ionizing radiation for diagnosis. Ionizing radiation includes digital mammography (DM) and digital breast tomosynthesis (DBT), as well as contrast-enhanced mammography (CEM), total breast CT (WBCT), and breast-specific gamma imaging (BSGI). ), Molecular Breast Imaging (MBI), and Positron Emission Mammography (PEM). Therefore, the increased risk of radiation exposure will continue to challenge the mammography market. On the other hand, the high costs associated with imaging systems and technologies will hinder the breast imaging market growth. Unfavourable redemption scenarios in developing and underdeveloped economies also pose significant challenges to the breast imaging market. However, strict regulatory approval procedures and the development of adverse conditions due to the occurrence of COVID-19 will limit and further impede breast imaging market growth during the 2026-2034 forecast period.
Breast Imaging Market Opportunities:
Recent advances in imaging technology have revolutionized the aspects of treatment and its access. The combination of imaging techniques such as CT scan, MRI, and PET is becoming increasingly important for visualizing metabolic information and anatomical details of organs. In addition, these integrated diagnostic imaging methods improved breast image quality and patient comfort, and reduced patient dose. Because of these benefits, manufacturers around the world are further focusing on introducing new products to increase the sensitivity and accuracy of a breast cancer diagnosis.
Breast Imaging Market Segment Analysis:
Based on the Technology: the Breast Imaging Market is segmented into Ionised, non-ionized breast imaging technology, and others. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the prediction interval. The growth of this segment may be due to the following non-ionized breast imaging techniques being superior to ionized breast imaging techniques: B. More anatomical details for diagnosis, more sensitivity to small breast lesions in women with dense breast tissue, and fewer false positives.
Based on End-user: the Breast Imaging Market is segmented into hospitals, ambulatory centers, diagnostic centers, and cancer care centers. Hospitals and clinics are expected to gain the largest market share in the market. The main factors that maintain the advantage of hospitals and clinics are increased investment in medical infrastructure development, increased purchasing power, availability of well-equipped operating and diagnostic rooms, and hospital-based medical services. Includes improved healthcare delivery. Increased investment in healthcare infrastructure development, increased purchasing power, availability of well-equipped operating and diagnostic rooms, and better healthcare delivery for hospital-based healthcare services are key factors driving hospital dominance.
Breast Imaging Market Regional Analysis:
North America currently holds the dominant position in the market, commanding a substantial revenue share of 39.47%, and this trend is anticipated to persist throughout the forecasted period, as affirmed by Strategic Market Research. The market's robust growth is propelled by key drivers, including the increasing prevalence of breast cancer, substantial research and development efforts in breast cancer therapies, and advancements in breast imaging technology. Cancer.Net reports that a staggering 3.8 million females are affected by breast cancer. The growth of the breast imaging market is further supported by investments in breast cancer screening programs undertaken by various organizations, such as the Society of Breast Imaging in the United States, dedicated to minimizing the impact of breast cancer and saving lives.
In the Asia-Pacific region, the market is experiencing the fastest growth, boasting a remarkable CAGR of 7.04%. By the end of 2034, the market is anticipated to reach $1 billion. The driving forces behind this growth include the escalating incidence of breast cancer, substantial investments in research and development for breast cancer therapies, and advancements in breast imaging technology. Breast cancer ranks as the most prevalent cancer in several Asia-Pacific countries, including China, Korea, Japan, Singapore, and Taiwan. The Centers for Disease Control (CDC) notes that breast cancer is among the most recurrent cancers in females, irrespective of their race and ethnicity. The region's increasing prevalence of breast cancer, coupled with the growing healthcare infrastructure, is expected to propel overall breast imaging market growth.
Breast Imaging Market Scope and Research Methodology:
The scope of the Market is extensively covered with in-depth analysis and market estimations. These reports encompass a comprehensive overview of industry trends, market dynamics, and growth prospects. They often provide insights into Market segmentation, competitive landscapes, and regional analysis. Methodologies employed involve extensive primary and secondary research, encompassing qualitative and quantitative assessments, including interviews with key industry participants, Market breakdowns by region, and growth rate analysis. Forecast parameters and impact analysis, such as COVID-19 impact, contribute to a holistic understanding of market trends.
Breast Imaging Market Recent Industry Developments
| Date | Company | Development | Impact |
|---|---|---|---|
| 15 April 2025 | iCAD, Inc. | Collaborated with Microsoft to integrate its AI-powered ProFound Breast Health Suite into Microsoft's Precision Imaging Network. | Scales access to high-precision mammography image analysis and workflow automation across health systems. |
| 16 September 2025 | ScreenPoint Medical | Selected its Transpara Breast AI solution for inclusion in the nationwide PRISM randomized controlled trial evaluating AI in screening mammography. | Drives large-scale clinical validation for AI-assisted breast cancer screening and density assessment in clinical practice. |
| 18 November 2025 | GE HealthCare | Secured FDA Premarket Approval for Pristina Recon DL, a deep-learning 3D mammography image reconstruction software. | Significantly improves image clarity and diagnostic speed while minimizing radiation dose requirements for patients. |
| 16 April 2026 | Quibim | Entered an exclusive strategic partnership with Vara to commercialize its AI breast cancer screening infrastructure across Spain. | Accelerates regional adoption of automated population-based mammography triage and reading workflows. |
| 16 June 2026 | Hologic, Inc. | Won a major patent infringement ruling against Siemens in the Unified Patent Court covering its core breast tomosynthesis focusing technology. | Reinforces market leadership and protects proprietary intellectual property in high-definition 3D mammography platforms. |
Breast Imaging Market Scope: Inquire before buying
| Global Breast Imaging Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 5.07 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 6.79% | Market Size in 2034: | USD 9.16 Bn. |
| Segments Covered: | by Technology | Ionic technology Non-Ionic Technology |
|
| by End User | Hospitals Ambulatory Centers Cancer Care Centers Diagnostic centers |
||
Breast Imaging Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Breast Imaging Market, Key Players are
1. Hologic Inc (USA)
2. GE Healthcare (USA)
3. Siemens Healthineers (Germany)
4. Koninklijke Philips N.V (Netherlands)
5. Fujifilm Holdings Corp. (Japan)
6. Canon Inc (Japan)
7. Aurora Healthcare (USA)
8. Allengers (India)
9. Dilon Technologies Inc (USA)
10. Planmed Oy (Finland)
11. Delphinus Medical Tech (USA)
12. Micrima Ltd (United Kingdom)
13. CMR Naviscan Corp (USA)
14. SuperSonic Imagine (France)
15. Carestream Health (USA)
16. Aurora Imaging Technology (USA)
17. GE Medical Systems (USA)
18. Sonomed Escalon (USA)
19. Metaltronica S.p.A. (Italy)
20. BMI Biomedical International s.r.l. (Italy)
21. IMS Giotto S.p.A. (Italy)
22.Agfa-Gevaert NV (Belgium)
23.CMR Surgical (United Kingdom)
24.Intrasense SA (France)
25.Sectra AB (Sweden)
Frequently Asked Questions:
1. What are the growth drivers for the market?
Ans. The increasing incidence and prevalence of breast cancer globally is expected to be the major drivers for the market.
2. What is the major restraint for the market growth?
Ans. Advanced breast imaging systems are expensive, which can limit access in less developed regions and impact healthcare budgets is expected to be the major restraining factor for the market growth.
3. Which region is expected to lead the global market during the forecast period?
Ans. North America is expected to lead the global market during the forecast period.
4. What was the Global Breast Imaging Market size in 2025?
Ans: The Global Breast Imaging Market size was USD 5.07 Billion in 2025.
5. What segments are covered in the Market report?
Ans. The segments covered in the market report are Technology and End user.